$LION
Lionsgate Studios Corp. Stock $lion

$lion Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000200619124000008 Filed on August 08, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024 Q1
Revenue	$823.7M	$588.4M	$0.00
YoY Change		-5.86%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin			$3.405M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.200M	$4.600M
YoY Change	10.53%	9.52%
% of Gross Profit
Operating Expenses			$3.405M
YoY Change
Operating Profit	-$34.80M	$15.60M
YoY Change	-145.79%	-57.84%
Interest Expense	$63.00M	$58.60M	$9.479M
YoY Change	523.07%	17.43%
% of Operating Profit		375.64%
Other Income/Expense, Net	-$13.80M	-$1.400M	-$911.5K
YoY Change	3820.45%	-63.16%
Pretax Income	-$108.9M	-$39.40M	$5.162M
YoY Change	-1289.35%	166.22%
Income Tax	$5.100M	$5.000M
% Of Pretax Income
Net Earnings	-$113.4M	-$43.50M	$5.162M
YoY Change	-1338.49%	112.2%
Net Earnings / Revenue	-13.77%	-7.39%
Basic Earnings Per Share	-$0.39	-$0.16
Diluted Earnings Per Share	-$0.39	-$0.16	$0.06
COMMON SHARES
Basic Shares Outstanding	288.7M shares	272.4M shares
Diluted Shares Outstanding	288.7M shares	272.4M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments			$437.2K
YoY Change
Cash & Equivalents	$210.8M	$167.2M	$277.0M
Short-Term Investments
Other Short-Term Assets	$328.0M	$373.0M	$373.1M
YoY Change	190553.34%
Inventory
Prepaid Expenses
Receivables	$496.8M	$578.0M	$688.6M
Other Receivables	$158.5M	$64.40M	$33.40M
Total Short-Term Assets	$1.194B	$1.183B	$1.372B
YoY Change	51.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$806.5M	$812.1M	$811.2M
YoY Change
Intangibles	$23.20M	$24.40M	$25.70M
YoY Change
Long-Term Investments			$804.2M
YoY Change
Other Assets	$779.3M	$789.1M	$852.9M
YoY Change
Total Long-Term Assets	$4.067B	$4.083B	$3.731B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$1.194B	$1.183B	$1.372B
Total Long-Term Assets	$4.067B	$4.083B	$3.731B
Total Assets	$5.261B	$5.266B	$5.103B
YoY Change	568.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$256.8M	$231.1M	$246.7M
YoY Change	35080.49%
Accrued Expenses	$178.6M	$273.1M	$282.4M
YoY Change
Deferred Revenue	$366.5M	$388.7M	$170.6M
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due	$443.0M	$716.3M	$860.3M
YoY Change
Total Short-Term Liabilities	$3.507B	$3.852B	$3.642B
YoY Change	480343.87%
LONG-TERM LIABILITIES
Long-Term Debt	$1.399B	$847.4M	$923.0M
YoY Change
Other Long-Term Liabilities	$430.7M	$440.1M	$452.5M
YoY Change	1424.89%
Total Long-Term Liabilities	$1.830B	$1.288B	$1.376B
YoY Change	6379.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.507B	$3.852B	$3.642B
Total Long-Term Liabilities	$1.830B	$1.288B	$1.376B
Total Liabilities	$6.200B	$6.069B	$6.130B
YoY Change	21299.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.452B	-$1.339B	-$1.249B
YoY Change
Common Stock	$289.7M	$289.3M	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.074B	-$960.8M	-$1.152B
YoY Change
Total Liabilities & Shareholders Equity	$5.261B	$5.266B	$5.103B
YoY Change	568.94%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$113.4M	-$43.50M	$5.162M
YoY Change	-1338.49%	112.2%
Depreciation, Depletion And Amortization	$4.200M	$4.600M
YoY Change	10.53%	9.52%
Cash From Operating Activities		-$117.6M	-$562.0K
YoY Change		-411.94%
INVESTING ACTIVITIES
Capital Expenditures		$4.100M
YoY Change		192.86%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities		-$41.10M	$0.00
YoY Change		608.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$299.0M
YoY Change
Cash From Financing Activities		$41.10M
YoY Change		137.57%
NET CHANGE
Cash From Operating Activities		-$117.6M	-562.0K
Cash From Investing Activities		-$41.10M	0.000
Cash From Financing Activities		$41.10M
Net Change In Cash		-$117.6M	-562.0K
YoY Change		-339.02%
FREE CASH FLOW
Cash From Operating Activities		-$117.6M	-$562.0K
Capital Expenditures		$4.100M
Free Cash Flow		-$121.7M
YoY Change		-435.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Film Monetized On Its Own And Film Group Impairment Statement Of Income Extensible List FilmMonetizedOnItsOwnAndFilmGroupImpairmentStatementOfIncomeExtensibleList	http://www.lionsgate.com/20240630#DirectOperatingCost http://www.lionsgate.com/20240630#RestructuringAndOtherItems
CY2024Q2	us-gaap	Film Monetized On Its Own And Film Group Impairment Statement Of Income Extensible List FilmMonetizedOnItsOwnAndFilmGroupImpairmentStatementOfIncomeExtensibleList	http://www.lionsgate.com/20240630#DirectOperatingCost http://www.lionsgate.com/20240630#RestructuringAndOtherItems
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q2	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherAssetsCurrent
CY2024Q2	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#OtherAssetsCurrent
CY2024Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	588400000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	625000000.0	usd
CY2024Q2	lion	Direct Operating Cost DirectOperatingCost	355800000	usd
CY2023Q2	lion	Direct Operating Cost DirectOperatingCost	362100000	usd
CY2024Q2	lion	Selling And Marketing Expenses SellingAndMarketingExpenses	92600000	usd
CY2023Q2	lion	Selling And Marketing Expenses SellingAndMarketingExpenses	129200000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	92100000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88400000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4600000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4200000	usd
CY2024Q2	lion	Restructuring And Other Items RestructuringAndOtherItems	27700000	usd
CY2023Q2	lion	Restructuring And Other Items RestructuringAndOtherItems	4100000	usd
CY2024Q2	us-gaap	Costs And Expenses CostsAndExpenses	572800000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	588000000.0	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15600000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	37000000.0	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	58600000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	49900000	usd
CY2024Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5100000	usd
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2200000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1400000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3800000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1000000.0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	900000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-300000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14800000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5000000.0	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6600000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-44400000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-21400000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-900000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-900000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-43500000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20500000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272400000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253400000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272400000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253400000	shares
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-44400000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-21400000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3000000.0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	900000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4600000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	16900000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-52000000.0	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3600000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-900000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-900000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-51100000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2700000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-778900000	usd
CY2023Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-20200000	usd
CY2023Q2	lion	Adjustments To Parent Net Investment Transfers AdjustmentsToParentNetInvestmentTransfers	-131200000	usd
CY2023Q2	lion	Temporary Equity Adjustment To Redemption Value TemporaryEquityAdjustmentToRedemptionValue	5900000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	17800000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-918400000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1150200000	usd
CY2024Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-43900000	usd
CY2024Q2	lion	Adjustments To Parent Net Investment Transfers AdjustmentsToParentNetInvestmentTransfers	-46400000	usd
CY2024Q2	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	33000000.0	usd
CY2024Q2	lion	Temporary Equity Adjustment To Redemption Value TemporaryEquityAdjustmentToRedemptionValue	200000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7600000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6600000	usd
CY2024Q2	lion	Stock Issued During Period Value Issued For Acquisitions And Pipe Investments Net Of Issuance Costs StockIssuedDuringPeriodValueIssuedForAcquisitionsAndPIPEInvestmentsNetOfIssuanceCosts	282700000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-926000000.0	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-44400000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-21400000	usd
CY2024Q2	lion	Depreciationand Amortization Excluding Amortizationof Films Television Programsand Program Rights Amortizationof Debt Issuance Costsand Other Amortization DepreciationandAmortizationExcludingAmortizationofFilmsTelevisionProgramsandProgramRightsAmortizationofDebtIssuanceCostsandOtherAmortization	4600000	usd
CY2023Q2	lion	Depreciationand Amortization Excluding Amortizationof Films Television Programsand Program Rights Amortizationof Debt Issuance Costsand Other Amortization DepreciationandAmortizationExcludingAmortizationofFilmsTelevisionProgramsandProgramRightsAmortizationofDebtIssuanceCostsandOtherAmortization	4200000	usd
CY2024Q2	lion	Film Monetizedon Its Own Film Monetizedin Film Groupand Entertainment License Agreementfor Program Material Amortization Expense FilmMonetizedonItsOwnFilmMonetizedinFilmGroupandEntertainmentLicenseAgreementforProgramMaterialAmortizationExpense	230500000	usd
CY2023Q2	lion	Film Monetizedon Its Own Film Monetizedin Film Groupand Entertainment License Agreementfor Program Material Amortization Expense FilmMonetizedonItsOwnFilmMonetizedinFilmGroupandEntertainmentLicenseAgreementforProgramMaterialAmortizationExpense	254100000	usd
CY2024Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	18000000.0	usd
CY2023Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
CY2024Q2	lion	Amortizationof Debt Issuance Costsand Other Non Cash Interest Expense AmortizationofDebtIssuanceCostsandOtherNonCashInterestExpense	7900000	usd
CY2023Q2	lion	Amortizationof Debt Issuance Costsand Other Non Cash Interest Expense AmortizationofDebtIssuanceCostsandOtherNonCashInterestExpense	6000000.0	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	12600000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	12200000	usd
CY2024Q2	lion	Other Amortization OtherAmortization	9900000	usd
CY2023Q2	lion	Other Amortization OtherAmortization	9200000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1000000.0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	900000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-300000	usd
CY2024Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	400000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-200000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-167700000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-82500000	usd
CY2024Q2	lion	Increase Decrease In Investment In Films And Television Programs IncreaseDecreaseInInvestmentInFilmsAndTelevisionPrograms	599400000	usd
CY2023Q2	lion	Increase Decrease In Investment In Films And Television Programs IncreaseDecreaseInInvestmentInFilmsAndTelevisionPrograms	374100000	usd
CY2024Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	11100000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1200000	usd
CY2024Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-37000000.0	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14500000	usd
CY2024Q2	lion	Increase Decrease In Participations And Residuals IncreaseDecreaseInParticipationsAndResiduals	-64400000	usd
CY2023Q2	lion	Increase Decrease In Participations And Residuals IncreaseDecreaseInParticipationsAndResiduals	-6600000	usd
CY2024Q2	lion	Increase Decrease In Content Related Payables IncreaseDecreaseInContentRelatedPayables	6700000	usd
CY2023Q2	lion	Increase Decrease In Content Related Payables IncreaseDecreaseInContentRelatedPayables	-5200000	usd
CY2024Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	212100000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	38200000	usd
CY2024Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-31000000.0	usd
CY2023Q2	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	53800000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-117600000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37700000	usd
CY2024Q2	lion	Paymentsto Acquire Equity Method Investmentsand Equity Securitieswithout Readily Determinable Fair Value PaymentstoAcquireEquityMethodInvestmentsandEquitySecuritieswithoutReadilyDeterminableFairValue	2000000.0	usd
CY2023Q2	lion	Paymentsto Acquire Equity Method Investmentsand Equity Securitieswithout Readily Determinable Fair Value PaymentstoAcquireEquityMethodInvestmentsandEquitySecuritieswithoutReadilyDeterminableFairValue	0	usd
CY2024Q2	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	35000000.0	usd
CY2023Q2	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	usd
CY2024Q2	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	usd
CY2023Q2	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	900000	usd
CY2024Q2	lion	Payments To Acquire Accounts Receivables Held For Collateral PaymentsToAcquireAccountsReceivablesHeldForCollateral	0	usd
CY2023Q2	lion	Payments To Acquire Accounts Receivables Held For Collateral PaymentsToAcquireAccountsReceivablesHeldForCollateral	49800000	usd
CY2024Q2	lion	Proceeds From Receipts Of Accounts Receivables Held For Collateral ProceedsFromReceiptsOfAccountsReceivablesHeldForCollateral	0	usd
CY2023Q2	lion	Proceeds From Receipts Of Accounts Receivables Held For Collateral ProceedsFromReceiptsOfAccountsReceivablesHeldForCollateral	46300000	usd
CY2024Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4100000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1400000	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41100000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5800000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	879500000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	490000000.0	usd
CY2024Q2	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	1066700000	usd
CY2023Q2	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	498700000	usd
CY2024Q2	lion	Proceeds From Film Related And Other Obligations ProceedsFromFilmRelatedAndOtherObligations	583200000	usd
CY2023Q2	lion	Proceeds From Film Related And Other Obligations ProceedsFromFilmRelatedAndOtherObligations	507700000	usd
CY2024Q2	lion	Repayment Of Film Related And Other Obligations RepaymentOfFilmRelatedAndOtherObligations	557900000	usd
CY2023Q2	lion	Repayment Of Film Related And Other Obligations RepaymentOfFilmRelatedAndOtherObligations	340900000	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	600000	usd
CY2024Q2	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	600000	usd
CY2023Q2	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2024Q2	lion	Payments To Proceeds From Parent Net Investment PaymentsToProceedsFromParentNetInvestment	90400000	usd
CY2023Q2	lion	Payments To Proceeds From Parent Net Investment PaymentsToProceedsFromParentNetInvestment	140200000	usd
CY2024Q2	lion	Proceeds From Business Combination ProceedsFromBusinessCombination	294000000.0	usd
CY2023Q2	lion	Proceeds From Business Combination ProceedsFromBusinessCombination	0	usd
CY2024Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41100000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17300000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-117600000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	49200000	usd
CY2024Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-200000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-800000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	334400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	251400000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	216600000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	299800000	usd
CY2024Q2	lion	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	330000000.0	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	254300000	usd
CY2024Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	299000000.0	usd
CY2024Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The most significant estimates made by management in the preparation of the financial statements relate to ultimate revenue and costs used for the amortization of investment in films and television programs; estimates related to the revenue recognition of sales or usage-based royalties; fair value of equity-based compensation; the allocations of costs to the Company for certain corporate and shared service functions in preparing the unaudited condensed consolidated financial statements for periods prior to the Separation on a carve-out basis; fair value of assets and liabilities for allocation of the purchase price of companies and assets acquired; income taxes including the assessment of valuation allowances for deferred tax assets; accruals for contingent liabilities; impairment assessments for investment in films and television programs, property and equipment, equity investments and goodwill. Actual results could differ from such estimates.</span></div>
CY2024Q2	lion	Stock Issued During Period Shares Number Of Additional Shares Issued StockIssuedDuringPeriodSharesNumberOfAdditionalSharesIssued	448127	shares
CY2024Q2	lion	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	35245430	shares
CY2024Q2	lion	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	253435794	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	288681224	shares
CY2024Q2	lion	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	253435794	shares
CY2024Q2	lion	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	75700000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	254300000	usd
CY2024Q2	lion	Gross Proceeds From Reverse Recapitalization Transaction GrossProceedsFromReverseRecapitalizationTransaction	330000000.0	usd
CY2024Q2	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	12500000	usd
CY2024Q2	lion	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	14700000	usd
CY2024Q2	lion	Proceeds From Reverse Recapitalization Transaction Net ProceedsFromReverseRecapitalizationTransactionNet	282700000	usd
CY2024Q2	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	11300000	usd
CY2024Q2	lion	Reverse Recapitalization Net ReverseRecapitalizationNet	294000000.0	usd
CY2024Q2	lion	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	75700000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	254300000	usd
CY2024Q2	lion	Proceeds From Issuance Of Private Placement Receivable ProceedsFromIssuanceOfPrivatePlacementReceivable	20000000.0	usd
CY2024Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	254200	shares
CY2024Q2	lion	Film Monetized On Its Own Number Of Films Acquired Film And Television Libraries FilmMonetizedOnItsOwnNumberOfFilmsAcquiredFilmAndTelevisionLibraries	46	film
CY2024Q2	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	0	usd
CY2024Q2	us-gaap	Film Monetized In Film Group Capitalized Cost Released FilmMonetizedInFilmGroupCapitalizedCostReleased	966100000	usd
CY2024Q1	us-gaap	Film Monetized In Film Group Capitalized Cost Released FilmMonetizedInFilmGroupCapitalizedCostReleased	992200000	usd
CY2024Q2	us-gaap	Film Monetized In Film Group Capitalized Cost Completed And Not Released FilmMonetizedInFilmGroupCapitalizedCostCompletedAndNotReleased	301900000	usd
CY2024Q1	us-gaap	Film Monetized In Film Group Capitalized Cost Completed And Not Released FilmMonetizedInFilmGroupCapitalizedCostCompletedAndNotReleased	225400000	usd
CY2024Q2	us-gaap	Film Monetized In Film Group Capitalized Cost Production FilmMonetizedInFilmGroupCapitalizedCostProduction	1011000000	usd
CY2024Q1	us-gaap	Film Monetized In Film Group Capitalized Cost Production FilmMonetizedInFilmGroupCapitalizedCostProduction	644400000	usd
CY2024Q2	us-gaap	Film Monetized In Film Group Capitalized Cost Development And Preproduction FilmMonetizedInFilmGroupCapitalizedCostDevelopmentAndPreproduction	66600000	usd
CY2024Q1	us-gaap	Film Monetized In Film Group Capitalized Cost Development And Preproduction FilmMonetizedInFilmGroupCapitalizedCostDevelopmentAndPreproduction	67000000.0	usd
CY2024Q2	us-gaap	Film Monetized In Film Group Capitalized Cost FilmMonetizedInFilmGroupCapitalizedCost	2345600000	usd
CY2024Q1	us-gaap	Film Monetized In Film Group Capitalized Cost FilmMonetizedInFilmGroupCapitalizedCost	1929000000	usd
CY2024Q2	lion	Film Monetized On Its Own Capitalized Costs Acquired Film And Television Libraries FilmMonetizedOnItsOwnCapitalizedCostsAcquiredFilmAndTelevisionLibraries	266400000	usd
CY2024Q2	lion	Film Monetized On Its Own Weighted Average Remaining Amortization Period Acquired Libraries FilmMonetizedOnItsOwnWeightedAverageRemainingAmortizationPeriodAcquiredLibraries	P13Y
CY2024Q1	lion	Film Monetized On Its Own Capitalized Costs Acquired Film And Television Libraries FilmMonetizedOnItsOwnCapitalizedCostsAcquiredFilmAndTelevisionLibraries	223100000	usd
CY2024Q2	lion	Film Monetized In Film Group And Entertainment License Agreement For Program Material Amortization Expense FilmMonetizedInFilmGroupAndEntertainmentLicenseAgreementForProgramMaterialAmortizationExpense	230500000	usd
CY2023Q2	lion	Film Monetized In Film Group And Entertainment License Agreement For Program Material Amortization Expense FilmMonetizedInFilmGroupAndEntertainmentLicenseAgreementForProgramMaterialAmortizationExpense	254100000	usd
CY2024Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	71300000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	68400000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6400000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6400000	usd
CY2024Q2	us-gaap	Investments Investments	77700000	usd
CY2024Q1	us-gaap	Investments Investments	74800000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	811200000	usd
CY2024Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-900000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	812100000	usd
CY2024Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1571200000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1793500000	usd
CY2024Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7500000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10200000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	1563700000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1783300000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	716300000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	860300000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	847400000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	923000000.0	usd
CY2024Q2	lion	Production And Related Loans Gross ProductionAndRelatedLoansGross	1306400000	usd
CY2024Q1	lion	Production And Related Loans Gross ProductionAndRelatedLoansGross	1292200000	usd
CY2024Q2	lion	Production Tax Credit Facility Gross ProductionTaxCreditFacilityGross	260000000.0	usd
CY2024Q1	lion	Production Tax Credit Facility Gross ProductionTaxCreditFacilityGross	260000000.0	usd
CY2024Q2	lion	Backlog Facility And Other Gross BacklogFacilityAndOtherGross	313000000.0	usd
CY2024Q1	lion	Backlog Facility And Other Gross BacklogFacilityAndOtherGross	287300000	usd
CY2024Q2	lion	Ip Credit Facility And Other Financing Obligations Gross IPCreditFacilityAndOtherFinancingObligationsGross	100600000	usd
CY2024Q1	lion	Ip Credit Facility And Other Financing Obligations Gross IPCreditFacilityAndOtherFinancingObligationsGross	109900000	usd
CY2024Q2	lion	Film Related Obligations Gross FilmRelatedObligationsGross	1980000000	usd
CY2024Q1	lion	Film Related Obligations Gross FilmRelatedObligationsGross	1949400000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	11400000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	11400000	usd
CY2024Q2	lion	Film Related Obligations Net FilmRelatedObligationsNet	1968600000	usd
CY2024Q1	lion	Film Related Obligations Net FilmRelatedObligationsNet	1938000000	usd
CY2024Q2	lion	Film Related Obligations Current FilmRelatedObligationsCurrent	1612100000	usd
CY2024Q1	lion	Film Related Obligations Current FilmRelatedObligationsCurrent	1393100000	usd
CY2024Q2	lion	Film Related Obligations Noncurrent FilmRelatedObligationsNoncurrent	356500000	usd
CY2024Q1	lion	Film Related Obligations Noncurrent FilmRelatedObligationsNoncurrent	544900000	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	123300000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	343600000	usd
CY2024Q2	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-500000	usd
CY2023Q2	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-1200000	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	300000	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	6000000.0	usd
CY2024Q2	lion	Temporary Equity Distributionsto Noncontrolling Interest TemporaryEquityDistributionstoNoncontrollingInterest	100000	usd
CY2023Q2	lion	Temporary Equity Distributionsto Noncontrolling Interest TemporaryEquityDistributionstoNoncontrollingInterest	600000	usd
CY2024Q2	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	usd
CY2023Q2	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	600000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	123000000.0	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	347200000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	194100000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	588400000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	625000000.0	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1013700000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	661200000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	72300000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	57100000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1804300000	usd
CY2024Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	89300000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6400000	usd
CY2024Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-400000	usd
CY2024Q2	lion	Accounts Receivable Allowance For Credit Loss Acquired AccountsReceivableAllowanceForCreditLossAcquired	2500000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	200000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8300000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	74100000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-43500000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-20500000	usd
CY2024Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	300000	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-43800000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-43800000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20500000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20500000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	272400000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	272400000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253400000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253400000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q2	lion	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	253400000	shares
CY2024Q2	lion	Trading Price Of Common Stock Per Share Price TradingPriceOfCommonStockPerSharePrice	16.05
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8400000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8000000.0	usd
CY2024Q2	lion	Corporate Allocation Of Share Based Compensation CorporateAllocationOfShareBasedCompensation	4200000	usd
CY2023Q2	lion	Corporate Allocation Of Share Based Compensation CorporateAllocationOfShareBasedCompensation	3700000	usd
CY2024Q2	lion	Share Based Payment Arrangement Expense Including Corporate Allocations ShareBasedPaymentArrangementExpenseIncludingCorporateAllocations	12600000	usd
CY2023Q2	lion	Share Based Payment Arrangement Expense Including Corporate Allocations ShareBasedPaymentArrangementExpenseIncludingCorporateAllocations	11700000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	500000	usd
CY2024Q2	lion	Share Based Compensation Expense After Accelerated Compensation Cost ShareBasedCompensationExpenseAfterAcceleratedCompensationCost	12600000	usd
CY2023Q2	lion	Share Based Compensation Expense After Accelerated Compensation Cost ShareBasedCompensationExpenseAfterAcceleratedCompensationCost	12200000	usd
CY2024Q2	lion	Share Based Compensation Expense After Accelerated Compensation Cost ShareBasedCompensationExpenseAfterAcceleratedCompensationCost	12600000	usd
CY2023Q2	lion	Share Based Compensation Expense After Accelerated Compensation Cost ShareBasedCompensationExpenseAfterAcceleratedCompensationCost	12200000	usd
CY2024Q2	lion	Restructuring And Other Items RestructuringAndOtherItems	27700000	usd
CY2023Q2	lion	Restructuring And Other Items RestructuringAndOtherItems	4100000	usd
CY2024Q2	lion	Restructuring Programming Content Changes And Other Expenses RestructuringProgrammingContentChangesAndOtherExpenses	30900000	usd
CY2023Q2	lion	Restructuring Programming Content Changes And Other Expenses RestructuringProgrammingContentChangesAndOtherExpenses	4200000	usd
CY2024Q2	us-gaap	Insurance Recoveries InsuranceRecoveries	2000000	usd
CY2024Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	588400000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	625000000.0	usd
CY2024Q2	lion	Gross Segment Contribution GrossSegmentContribution	143200000	usd
CY2023Q2	lion	Gross Segment Contribution GrossSegmentContribution	134200000	usd
CY2024Q2	lion	Segment General And Administration SegmentGeneralAndAdministration	46400000	usd
CY2023Q2	lion	Segment General And Administration SegmentGeneralAndAdministration	42100000	usd
CY2024Q2	lion	Segment Profit Loss SegmentProfitLoss	96800000	usd
CY2023Q2	lion	Segment Profit Loss SegmentProfitLoss	92100000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	15600000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	37000000.0	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	58600000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	49900000	usd
CY2024Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5100000	usd
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2200000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1400000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3800000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1000000.0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	900000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-300000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14800000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4600000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4200000	usd
CY2024Q2	lion	Adjusted Depreciation And Amortization AdjustedDepreciationAndAmortization	3600000	usd
CY2023Q2	lion	Adjusted Depreciation And Amortization AdjustedDepreciationAndAmortization	2800000	usd
CY2024Q2	lion	Share Based Compensation Expense After Accelerated Compensation Cost ShareBasedCompensationExpenseAfterAcceleratedCompensationCost	12600000	usd
CY2023Q2	lion	Share Based Compensation Expense After Accelerated Compensation Cost ShareBasedCompensationExpenseAfterAcceleratedCompensationCost	12200000	usd
CY2024Q2	lion	Share Based Payment Arrangement Expense Including Corporate Allocations ShareBasedPaymentArrangementExpenseIncludingCorporateAllocations	12600000	usd
CY2023Q2	lion	Share Based Payment Arrangement Expense Including Corporate Allocations ShareBasedPaymentArrangementExpenseIncludingCorporateAllocations	11700000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	92100000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	88400000	usd
CY2024Q2	us-gaap	Maximum Remaining Maturity Of Foreign Currency Derivatives1 MaximumRemainingMaturityOfForeignCurrencyDerivatives1	P22M
CY2024Q2	lion	Direct Operating Cost DirectOperatingCost	355800000	usd
CY2023Q2	lion	Direct Operating Cost DirectOperatingCost	362100000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	58600000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	49900000	usd
CY2024Q2	us-gaap	Derivative Assets DerivativeAssets	28100000	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1600000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	35600000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2800000	usd
CY2024Q2	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	4100000	usd
CY2024Q2	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	31100000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	167200000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	277000000.0	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	36600000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	43700000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	12800000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	13700000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	216600000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	334400000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35800000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34800000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	36600000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	43700000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	54100000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	59900000	usd
CY2024Q2	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	28100000	usd
CY2024Q1	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	35600000	usd
CY2024Q2	lion	Tax Credits Receivable Current TaxCreditsReceivableCurrent	218400000	usd
CY2024Q1	lion	Tax Credits Receivable Current TaxCreditsReceivableCurrent	199100000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	373000000.0	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	373100000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	14900000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	18300000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	12800000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	13700000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	82600000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	111700000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	4000000.0	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	3200000	usd
CY2024Q2	lion	Tax Credits Receivable Noncurrent TaxCreditsReceivableNoncurrent	356500000	usd
CY2024Q1	lion	Tax Credits Receivable Noncurrent TaxCreditsReceivableNoncurrent	361700000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	318300000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	344300000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	789100000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	852900000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	109700000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	116200000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	700000	usd
CY2024Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	8300000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	25400000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	7600000	usd

Files In Submission

Name	View Source	Status
0002006191-24-000008-index-headers.html	Edgar Link	pending
0002006191-24-000008-index.html	Edgar Link	pending
0002006191-24-000008.txt	Edgar Link	pending
0002006191-24-000008-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lion-20240630.htm	Edgar Link	pending
lion-20240630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
lion-20240630_cal.xml	Edgar Link	unprocessable
lion-20240630_def.xml	Edgar Link	unprocessable
lion-20240630_lab.xml	Edgar Link	unprocessable
lion-20240630_pre.xml	Edgar Link	unprocessable
lion-20240630_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
studioex311q1f202510-q.htm	Edgar Link	pending
studioex312q1f202510-q.htm	Edgar Link	pending
studioex321q1f202510-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LION
Lionsgate Studios Corp. Stock $lion

2024 Q3 Form 10-Q Financial Statement

#000200619124000008 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LION Lionsgate Studios Corp. Stock $lion

2024 Q3 Form 10-Q Financial Statement

#000200619124000008 Filed on August 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LION
Lionsgate Studios Corp. Stock $lion